A non-invasive prenatal paternity test (NIPP) determines the biological father of a baby during pregnancy using a simple blood draw from the mother and a cheek swab from the alleged father. It can be done as early as 7 weeks into pregnancy. Unlike older methods that required inserting a needle into the uterus, this test carries no risk of miscarriage because it never touches the pregnancy itself.
How the Test Works
During pregnancy, the placenta constantly sheds tiny fragments of DNA into the mother’s bloodstream. These fragments, called cell-free fetal DNA, float alongside the mother’s own DNA in her blood plasma. The lab draws a standard blood sample from the mother and separates out these fetal DNA fragments, then compares them to the DNA collected from the alleged father’s cheek swab.
The fetal fragments are notably shorter than the mother’s DNA, roughly 142 base pairs compared to about 162 for maternal fragments. Labs can exploit this size difference to isolate and amplify the fetal material, increasing the proportion of baby DNA in the sample by nearly fourfold in some cases. Once enough fetal DNA is isolated, the lab uses high-throughput sequencing technology to read thousands of genetic markers and determine whether the alleged father’s DNA matches the baby’s.
Most modern labs analyze single nucleotide polymorphisms (SNPs), which are tiny, naturally occurring variations scattered across human DNA. Some systems check over 5,000 SNP markers in a single run. By comparing which variants the baby inherited to the alleged father’s profile, the lab calculates a statistical likelihood of paternity.
Accuracy
When there is sufficient fetal DNA in the sample, these tests are highly accurate. Studies using high-throughput sequencing have reported paternity inclusion probabilities exceeding 99.9999% across all tested cases. In one study of 30 cases, paternity was correctly determined in every single one. Another analysis of 21 cases resolved 20 successfully, with the single failure caused by too little fetal DNA in the sample rather than an incorrect result.
The key factor is something called the fetal fraction: the percentage of total cell-free DNA in the mother’s blood that actually comes from the baby. If the fetal fraction is too low, the lab may not be able to produce a result at all. This is more likely very early in pregnancy, in women with higher body weight (since more maternal DNA dilutes the fetal signal), or in certain assisted reproduction scenarios. A low fetal fraction doesn’t produce a wrong answer. It produces no answer, and the lab will typically ask you to retest later in pregnancy.
When You Can Take It
The test is available starting at 7 weeks of pregnancy, which is just a few weeks after most people learn they’re pregnant. There is no upper gestational limit. The fetal fraction in maternal blood generally increases as pregnancy progresses, so testing later tends to yield stronger results. That said, most people who seek this test want answers early, and 7 weeks is the industry standard for the earliest reliable window.
What the Collection Involves
The mother provides a blood sample, drawn from the arm like any routine blood test. The alleged father provides a cheek swab, rubbing the inside of his cheek with a collection stick. The two samples don’t need to be collected at the same appointment or even the same location. One practical note: some labs will not draw the mother’s blood on a Friday, because the sample needs to reach the lab while it’s still viable. Staying well hydrated before the blood draw is recommended.
Cost and Results Timeline
Pricing depends on whether you need results for personal knowledge or for legal purposes. At-home (informational) paternity tests from major labs start around $210, while legally admissible tests start around $525. Non-invasive prenatal versions typically cost more than standard postnatal tests because the lab work is more complex. Expect to pay somewhere in the range of $1,000 to $2,000 for a prenatal test from an established provider, though prices vary.
Results generally take 5 to 10 business days after the lab receives both samples, depending on the provider and the type of test ordered.
Legal Admissibility
Not all paternity tests hold up in court. For a test result to be legally admissible, many states require it to come from a facility accredited by the AABB (formerly the American Association of Blood Banks). AABB-accredited labs follow strict chain-of-custody procedures, meaning every sample is tracked, verified, and documented from the moment it’s collected to the moment results are reported. This ensures the samples weren’t tampered with or mixed up.
If you’re getting tested for personal peace of mind, an at-home collection kit works fine. If you anticipate needing results for child support, custody, or any legal proceeding, make sure you choose a legally admissible test with proper chain of custody from the start. You generally cannot convert an informational result into a legal one after the fact.
How It Compares to Invasive Methods
Before non-invasive testing became available, the only way to determine paternity during pregnancy was through amniocentesis or chorionic villus sampling (CVS). Both involve inserting a needle or catheter through the abdomen or cervix to collect fetal cells directly. Amniocentesis is typically done between weeks 15 and 20, and CVS between weeks 10 and 13. Both carry a small but real risk of miscarriage, generally estimated at 0.1% to 0.3%.
The non-invasive test eliminates that risk entirely. It is just as accurate when the fetal fraction is adequate, can be performed earlier (at 7 weeks versus 10 to 15), and requires no recovery time or special precautions afterward.
Situations Where the Test May Not Work
Several scenarios can complicate or prevent a reliable result:
- Twin pregnancies: Fetal fraction tends to be lower with twins, and failure rates range from 1.6% to 13.2%, compared to lower rates for singleton pregnancies. In fraternal twins, one baby may contribute far less DNA than the other, potentially skewing results or causing test failure even when the overall fetal fraction looks acceptable.
- Egg donation or surrogacy: SNP-based testing platforms don’t work reliably when the genetic mother and the person carrying the pregnancy are different people. The DNA shed by the placenta reflects the egg donor’s genetics, which interferes with the ability to distinguish fetal alleles.
- Vanishing twin: If a twin pregnancy was initially present but one embryo stopped developing, residual DNA from the lost twin can persist in the mother’s blood and confuse the analysis.
- Bone marrow transplant or recent blood transfusion: These introduce foreign DNA into the mother’s bloodstream, making it difficult for the lab to distinguish fetal DNA from donor DNA.
- Closely related alleged fathers: If two potential fathers are close biological relatives (brothers, for instance), the genetic overlap between them can make it harder to distinguish which one is the biological father. Additional markers or more advanced testing may be needed.
In any of these situations, discuss your circumstances with the testing provider before ordering. They can advise whether the test is likely to produce a reliable result or whether an alternative approach would be better.